Alivecor Inc. has received U.S. FDA clearance for a six-lead ECG known as Kardiamobile 6L. It will start retailing in mid-June for $149 but is available for preorder. This is slated to complement the existing one-lead product Kardiamobile, which sells for $99 and has started to face competition with single-lead ECG watch products from Apple Inc. and Verily Life Sciences LLC. Read More
